KEY FEATURES
Full Name | Tumor Necrosis Factor Receptor Superfamily, Member 1A |
---|---|
Synonym | TNF-R;TNF-R-I;TNF-R55;TNFAR;TNFR1;TNFR1-d2;TNFR55;TNFR60;p55;p55-R;p60;CD120a;FPF;MS5;TBP1; |
Assay Type | Sandwich |
Reactivity | Human |
Range | 7.81-500pg/mL |
Sensitivity | 4.69pg/mL |
Sample Type | Serum,plasma and other biological fluids |
Sample Volume | 100μL |
Detection Wavelength | OD450 |
Transportation Temperature | 2-8°C |
Specificity | The kit detected Human TNFRSF9 in the samples and no significant cross-species reactions were found |
Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TNFRSF9. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TNFRSF9 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TNFRSF9, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TNFRSF9. You can calculate the concentration of Human TNFRSF9 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
Components | Specifications | Storage and Notes |
---|---|---|
Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TNFRSF9 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Intra-assay Precision | Inter-assay Precision | |||||
---|---|---|---|---|---|---|
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 24.2 | 76.03 | 199.6 | 25.43 | 81.98 | 208.78 |
Standard deviation | 1.55 | 3.9 | 10.36 | 1.55 | 4.25 | 9.37 |
CV(%) | 6.4 | 5.13 | 5.19 | 6.1 | 5.18 | 4.49 |
RECOVERY
The recovery of Human TNFRSF9 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
Sample Type | Range (%) | Average Recovery (%) |
---|---|---|
Serum(n=8) | 94-109 | 100 |
EDTA plasma (n=8) | 94-107 | 100 |
Cell culture media (n=8) | 89-101 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TNFRSF9 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with TNFRSF9 ELISA Kits
TNFSF9 ELISA Kit | publications with TNFRSF9 and TNFSF9 |
TNFRSF4 ELISA Kit | publications with TNFRSF9 and TNFRSF4 |
TRAF2 ELISA Kit | publications with TNFRSF9 and TRAF2 |
TRAF1 ELISA Kit | publications with TNFRSF9 and TRAF1 |
TRAF3 ELISA Kit | publications with TNFRSF9 and TRAF3 |
LRR1 ELISA Kit | publications with TNFRSF9 and LRR1 |
Pathways associated with TNFRSF9 ELISA Kit
Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
Downstream Signaling In Naive CD8+ T Cells Pathway | Downstream Signaling In Naive CD8+ T Cells Pathway |
TCR Signaling Pathway | TCR Signaling Pathway |
Diseases associated with TNFRSF9 ELISA Kit
Necrosis | publications with TNFRSF9 and Necrosis |
Neoplasms | publications with TNFRSF9 and Neoplasms |
Immune System Diseases | publications with TNFRSF9 and Immune System Diseases |
Inflammation | publications with TNFRSF9 and Inflammation |
Liver Diseases | publications with TNFRSF9 and Liver Diseases |
Lung Neoplasms | publications with TNFRSF9 and Lung Neoplasms |
Nervous System Diseases | publications with TNFRSF9 and Nervous System Diseases |
Asthma | publications with TNFRSF9 and Asthma |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | publications with TNFRSF9 and Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Liver Neoplasms | publications with TNFRSF9 and Liver Neoplasms |
Organs/Tissues associated with TNFRSF9 ELISA Kit
Blood | publications with TNFRSF9 and Blood |
Lung | publications with TNFRSF9 and Lung |
Intestine | publications with TNFRSF9 and Intestine |
Brain | publications with TNFRSF9 and Brain |
Pancreas | publications with TNFRSF9 and Pancreas |
Pharynx | publications with TNFRSF9 and Pharynx |
Uterus | publications with TNFRSF9 and Uterus |
Kidney | publications with TNFRSF9 and Kidney |